Lock solution for venous catheters using sodium bicarbonate
09789227 · 2017-10-17
Inventors
Cpc classification
A61L29/16
HUMAN NECESSITIES
A61L2300/42
HUMAN NECESSITIES
A61M25/0017
HUMAN NECESSITIES
A61M2025/0056
HUMAN NECESSITIES
A61L2300/102
HUMAN NECESSITIES
A61M2025/0019
HUMAN NECESSITIES
International classification
Abstract
A Sodium Bicarbonate Catheter Lock Solution that prevents clot formation inside the catheter lumen and ensures patency of the catheter and also eliminates bleeding and other complications caused through the use of anticoagulants and other solutions as a catheter locking solution. Said lock solution may be used with or without other components such as antimicrobials/antibiotics and/or anti-coagulants/anti-clotting agents.
Claims
1. A method of preventing catheter occlusion or thrombosis in a catheter during dwell time, consisting of the steps of: providing a patient with a central catheter for vascular access; and inserting into a lumen of said catheter a stand-alone anti-clotting lock solution consisting of 8.4% of sodium bicarbonate “and an antimicrobial agent” to mitigate clotting within said lock solution in order to keep patency when said catheter is not being used for treatment of a patient.
2. The method of preventing catheter occlusion or thrombosis in a catheter during dwell time of claim 1, wherein said catheter is a non-tunneled central catheter with single, double or triple lumen.
3. The method of preventing catheter occlusion or thrombosis in a catheter during dwell time of claim 1, wherein said catheter is a tunneled catheter adapted to lie in a subcutaneous tunnel.
Description
BRIEF DESCRIPTION OF THE DRAWING FIGURES
(1) In order that the invention may be more fully understood, it will now be described, by way of example, with reference to the accompanying drawing in which:
(2)
(3)
(4)
(5)
(6)
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
(7) The following discussion describes in detail one embodiment of the invention (and several variations of that embodiment). This discussion should not be construed, however, as limiting the invention to those particular embodiments, practitioners skilled in the art will recognize numerous other embodiments as well. For definition of the complete scope of the invention, the reader is directed to appended claims.
(8) Referring to
(9) In regard to prior art catheter lock solutions placed in the catheter lumen 24, compounds such as heparin 16, citrate 18, and sodium chloride 20, are used in various combinations and concentrations. As aforementioned, heparin has the disadvantage of possibly inducing bleeding (since it is an anticoagulant) and citrate solution also has potentially hazardous side effects.
(10) Referring now to
(11) Referring to
(12) No studies were found using Sodium Bicarbonate as a vascular lock solution, therefore, its anticoagulant principle cannot be definitively explained. It can be speculated that it works by binding calcium and removing it from the many enzymes of the coagulation system that require it as a co-factor.
(13) It should be emphasized that Sodium Bicarbonate is readily available and inexpensive. Its availability is enhanced since it is commonly used for treatment of metabolic acidosis.
(14) While certain novel features of this invention have been shown and described and are pointed out in the annexed claims, it is not intended to be limited to the details above, since it will be understood that various omissions, modifications, substitutions and changes in the forms and details of the device illustrated and in its operation can be made by those skilled in the art without departing in any way from the spirit of the present invention.
(15) Without further analysis, the foregoing will so fully reveal the gist of the present invention that others can, by applying current knowledge, readily adapt it for various applications without omitting features that, from the standpoint of prior art, fairly constitute essential characteristics of the generic or specific aspects of this invention.